Ashley McEvoy, executive vice president, worldwide chair of Johnson & Johnson’s medtech business, said the company’s orthopedics sector — such as hips and trauma — is gaining market share, but spine has been losing ground.
Johnson & Johnson said it will develop a spine robot on the back of the success of its Velys system for total knee replacement, which recently surpassed 10,000 cases, according to the company.
Ms. McEvoy did not provide a timeline for the robot but said “three important innovations” are expected to reshape the company’s spine portfolio “in the next couple of years.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
